Delivery Order SPE2DB20D1047-SPE2DB25FF83Q
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,287.25 by the Defense Logistics Agency's Medical Supply Chain on August 15, 2025, for the supply of Zilretta 32 mg vials. The competitively awarded, firm fixed-price contract carries an ultimate completion date of September 8, 2025, and involves performance at the vendor's Conshohocken facility. This delivery order represents a child contract...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) for Zilretta 32 mg vials valued at $8,915.76 under a firm fixed-price contract structure. The award was made on August 4, 2025, with an ultimate completion date of August 25, 2025. This delivery order represents a non-set-aside competitive procurement, with performance to be completed at the contractor's corporate office location in Conshohocken, Pennsylvania. Zilretta is an intra-articular injection...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, valued at $1,485.96 with a firm fixed price structure. The contract, awarded on August 13, 2025, carries an ultimate completion date of September 4, 2025, and represents a non-set-aside competitive award. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order falls...
- The Defense Logistics Agency awarded a $3,714.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with an ultimate completion date of October 2, 2025. This is a competitively awarded, non-set-aside contract issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,485.96 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with a completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively through the federal procurement process. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $8,915.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Zilretta 32 mg vials, with an ultimate completion date of August 13, 2025. This non-set-aside contract, executed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, represents a child delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen is a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,485.96 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's facility in...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,752.85 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to provide ZILRETTA 32 MG VIALS. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp by DLA to deliver pharmaceutical products and medical supplies in support of military treatment programs and facilities...
- The Defense Logistics Agency awarded a delivery order valued at $3,714.90 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zilretta 32 mg vials, with an ultimate completion date of October 1, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The product...
- The Defense Logistics Agency awarded a $3,714.90 delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of August 12, 2025. This is a firm fixed price, non-set-aside contract awarded on July 22, 2025, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. Zilretta is an intra-articular injection used for osteoarthritis pain management, indicating this procurement supports military healthcare needs for pain...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF83QDelivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $4,457.88 by the Defense Logistics Agency (DLA) for the supply of Zilretta 32 mg vials, with an ultimate completion date of October 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Zilretta, a specialized pain management pharmaceutical, reflects the company's established capability to fulfill federal medical supply requirements through open competition and demonstrates its ongoing role as a key supplier supporting Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 9/12/25 |